Stefanie M. Bode‐Böger

16.0k total citations · 2 hit papers
202 papers, 12.9k citations indexed

About

Stefanie M. Bode‐Böger is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Biochemistry. According to data from OpenAlex, Stefanie M. Bode‐Böger has authored 202 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Physiology, 90 papers in Cardiology and Cardiovascular Medicine and 27 papers in Biochemistry. Recurrent topics in Stefanie M. Bode‐Böger's work include Nitric Oxide and Endothelin Effects (108 papers), Renin-Angiotensin System Studies (33 papers) and Cardiovascular Issues in Pregnancy (32 papers). Stefanie M. Bode‐Böger is often cited by papers focused on Nitric Oxide and Endothelin Effects (108 papers), Renin-Angiotensin System Studies (33 papers) and Cardiovascular Issues in Pregnancy (32 papers). Stefanie M. Bode‐Böger collaborates with scholars based in Germany, United States and Hungary. Stefanie M. Bode‐Böger's co-authors include Rainer H. Böger, Jens Martens‐Lobenhoffer, Jürgen C. Frölich, Jan T. Kielstein, Danilo Fliser, Dimitrios Tsikas, John P. Cooke, Hermann Haller, Philip S. Tsao and Jason R. Chan and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

Stefanie M. Bode‐Böger

201 papers receiving 12.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction

1998 1000 citations Rainer H. Böger, Stefanie M. Bode‐Böger et al. profile →
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

2001 891 citations Carmine Zoccali, Stefanie M. Bode‐Böger et al. The Lancet profile →

Peers

Countries citing papers authored by Stefanie M. Bode‐Böger

Since Specialization

Citations

This map shows the geographic impact of Stefanie M. Bode‐Böger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie M. Bode‐Böger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie M. Bode‐Böger more than expected).

Fields of papers citing papers by Stefanie M. Bode‐Böger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie M. Bode‐Böger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie M. Bode‐Böger. The network helps show where Stefanie M. Bode‐Böger may publish in the future.

Co-authorship network of co-authors of Stefanie M. Bode‐Böger

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie M. Bode‐Böger. A scholar is included among the top collaborators of Stefanie M. Bode‐Böger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie M. Bode‐Böger. Stefanie M. Bode‐Böger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantification of isavuconazole from dried blood spots: Applicability in therapeutic drug monitoring 2025 ·Journal of Chromatography B ·Jens Martens‐Lobenhoffer, Stefan Angermair, Stefanie M. Bode‐Böger	1
2	Symmetric dimethylguanidino valeric acid, a novel single biomarker of hepatic steatosis 2024 ·iScience ·Roman N. Rodionov, Natalia Jarzebska, Yen Chin Koay, Mengbo Li, Matthias Kühn, Stefan R. Bornstein, Jens Martens‐Lobenhoffer, Mohammed Eslam, (unknown), (unknown), Alexander G. Markov, Norbert Weiss, Andreas L. Birkenfeld, Peter Schwarz, Stefanie M. Bode‐Böger, Nikolaos Perakakis, John O’Sullivan, Jacob George	1
3	Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19 2022 ·Journal of Chromatography B ·Jens Martens‐Lobenhoffer, (unknown), Jan T. Kielstein, Stefanie M. Bode‐Böger	29
4	The role of alanine glyoxylate transaminase-2 (agxt2) in β-alanine and carnosine metabolism of healthy mice and humans 2020 ·European Journal of Applied Physiology ·Jan Stautemas, Natalia Jarzebska, (unknown), Laura Blancquaert, Inge Everaert, (unknown), Siegrid De Baere, (unknown), (unknown), (unknown), Jens Martens‐Lobenhoffer, Stefanie M. Bode‐Böger, Chang Keun Kim, James Leiper, Norbert Weiss, Siska Croubels, (unknown), Wim Derave	4
5	A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2 2016 ·Scientific Reports ·(unknown), Elisa Oppici, Jens Martens‐Lobenhoffer, Natalia Jarzebska, (unknown), (unknown), (unknown), (unknown), James Leiper, Renke Maas, Barbara Cellini, Norbert Weiss, Stefanie M. Bode‐Böger	30
6	Role of the endogenous nitric oxide inhibitor asymmetric dimethylarginine (ADMA) and brain-derived neurotrophic factor (BDNF) in depression and behavioural changes: clinical and preclinical data in chronic kidney disease 2015 ·Nephrology Dialysis Transplantation ·Heike Kielstein, (unknown), (unknown), Song Rong, Sabrina Schneider, Jens Martens‐Lobenhoffer, Kristin Jäger, Stefanie M. Bode‐Böger, Jan T. Kielstein	44
7	Intravenous colistin in a patient with serious burns and borderline syndrome: The benefits of therapeutic drug monitoring 2013 ·International Journal of Antimicrobial Agents ·Stefanie M. Bode‐Böger, (unknown), Uwe Tröger, Jens Martens‐Lobenhoffer, (unknown), P. Mailänder	29
8	Asymmetrical Dimethylarginine - More Sensitive than NT-proBNP to Diagnose Heart Failure in Adults with Congenital Heart Disease 2012 ·PLoS ONE ·Oktay Tutarel, (unknown), Stefanie M. Bode‐Böger, Jens Martens‐Lobenhoffer, Svjetlana Lovric, Johann Bauersachs, Bernhard Schieffer, Mechthild Westhoff‐Bleck, Jan T. Kielstein	25
9	Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring 2012 ·International Journal of Antimicrobial Agents ·Uwe Tröger, (unknown), Jens Martens‐Lobenhoffer, Ivan Tanev, Ruediger C. Braun‐Dullaeus, Stefanie M. Bode‐Böger	55
10	Determination of micafungin and anidulafungin in human plasma: UV- or mass spectrometric quantification? 2011 ·Journal of Chromatography B ·Jens Martens‐Lobenhoffer, (unknown), Stefanie M. Bode‐Böger	24
11	High Plasma Dimethylarginine Levels are Associated with Adverse Clinical Outcome After Stroke 2011 ·Journal of Atherosclerosis and Thrombosis ·Hans Worthmann, Shufen Chen, Jens Martens‐Lobenhoffer, Na Li, (unknown), Anita B. Tryc, Annemarie Goldbecker, Qiang Dong, Jan T. Kielstein, Stefanie M. Bode‐Böger, Karin Weißenborn	42
12	The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA 2009 ·International Journal of Cardiology ·Andreas Goette, (unknown), Kathleen Jentsch‐Ullrich, Jens Martens‐Lobenhoffer, Fortunato Scalera, Uwe Lendeckel, Stefanie M. Bode‐Böger	6
13	Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient 2008 ·Scandinavian Journal of Infectious Diseases ·(unknown), (unknown), Olaf Burkhardt, Jens Martens‐Lobenhoffer, Stefanie M. Bode‐Böger, Jan T. Kielstein, Marcus Hiß	10
14	Elevated plasma asymmetric dimethyl‐L‐arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis 2007 ·Arthritis & Rheumatism ·Andrzej Surdacki, Jens Martens‐Lobenhoffer, (unknown), (unknown), Tomasz Rakowski, (unknown), Jacek S. Dubiel, J Pryjma, Stefanie M. Bode‐Böger	92
15	Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study breakdown → 2001 ·The Lancet ·Carmine Zoccali, Stefanie M. Bode‐Böger, Francesca Mallamaci, Frank Benedetto, Giovanni Tripepi, Lorenzo Malatino, Alessandro Cataliotti, Ignazio Bellanuova, Isabella Fermo, Jürgen C. Frölich, Rainer H. Böger	891
16	Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease 2001 ·Kidney International ·Jan T. Kielstein, Stefanie M. Bode‐Böger, Jürgen C. Frölich, Hermann Haller, Rainer H. Böger	59
17	An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes 2000 ·Journal of the American College of Cardiology ·Rainer H. Böger, Stefanie M. Bode‐Böger, Philip S. Tsao, Patrick S. Lin, Jason R. Chan, John P. Cooke	205
18	Effect of Lovastatin on Plaque Formation and Ldl Oxidation in Cholesterol-Fed Rabbits 1998 ·Laddawal Phivthong‐ngam, Rainer H. Böger, Stefanie M. Bode‐Böger, M. Böhme, (unknown), J. C. Frölich	1
19	Dietary l-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms 1998 ·Atherosclerosis ·Rainer H. Böger, Stefanie M. Bode‐Böger, (unknown), Ralf P. Brandes, Edzard Schwedhelm, Andreas Mügge, M. Böhme, Dimitrios Tsikas, Jürgen C. Frölich	84
20	Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension. 1996 ·PubMed ·(unknown), Andreas Mügge, Stefanie M. Bode‐Böger, (unknown), (unknown), Frölich Jc	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact